Maternal and cord blood hormone levels in the United States and China and the intrauterine origin of breast cancer

Annals of Oncology

Volumn 22, Issue 5, 2011, Pages 1102-1108

  Lagiou, P ^a,b   Samoli, E ^b   Okulicz, W ^c   Xu, B ^d   Lagiou, A ^e   Lipworth, L ^f   Georgila, C ^b   Vatten, L ^g   Adami, H O ^a,h   Trichopoulos, D ^a   Hsieh, C C ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d FUDAN UNIVERSITY   (China)

^e UNIVERSITY OF WEST ATTICA   (Greece)

^f INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^g NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^h KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Breast cancer; Cord blood; Hormones; IGF; Pregnancy; SHBG

Indexed keywords

ADIPONECTIN; ESTRADIOL; ESTRIOL; PROGESTERONE; PROLACTIN; SEX HORMONE BINDING PROTEIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TESTOSTERONE;

ADULT; ARTICLE; BREAST CANCER; CAUCASIAN; CHINA; CHINESE; CONTROLLED STUDY; CORRELATION ANALYSIS; ESTRADIOL BLOOD LEVEL; ESTRIOL BLOOD LEVEL; FEMALE; GESTATIONAL AGE; HORMONE BLOOD LEVEL; HUMAN; MALE; MATERNAL BLOOD; NEWBORN; PREDICTION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; UMBILICAL CORD BLOOD; UNITED STATES;

EID: 79955488600     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq565     Document Type: Article

References (22)

1. Trichopoulos D. Hypothesis: does breast cancer originate in utero? Lancet 1990; 335: 939-940.
2. Michels KB, Xue F. Role of birthweight in the etiology of breast cancer. Int J Cancer 2006; 119: 2007-2025.
3. Xue F, Michels KB. Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence. Lancet Oncol 2007; 8: 1088-1100.
4. dos Santos Silva I, De Stavola B, McCormack V; Collaborative Group on Pre-Natal Risk Factors and Subsequent Risk of Breast Cancer. Birth size and breast cancer risk: re-analysis of individual participant data from 32 studies. PLoS Med 2008; 5: e193.
5. Park SK, Kang D, McGlynn KA et al. Intrauterine environments and breast cancer risk: meta-analysis and systematic review. Breast Cancer Res 2008; 10(1): R8.
6. Lipworth L, Hsieh C-C, Wide L et al. Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br J Cancer 1999; 79: 7-12.
7. Wuu J, Hellerstein S, Lipworth L et al. Correlates of pregnancy oestrogen, progesterone and sex hormone-binding globulin in the USA and China. Eur J Cancer Prev 2002; 11: 283-293.
8. Schernhammer ES. In-utero exposures and breast cancer risk: joint effect of estrogens and insulin-like growth factor? Cancer Causes Control 2002; 13: 505-508.
9. Troisi R, Potischman N, Johnson CN et al. Estrogen and androgen concentrations are not lower in the umbilical cord serum of pre-eclamptic pregnancies. Cancer Epidemiol Biomarkers Prev 2003; 12: 1268-1270.
10. Xu B, Lipworth L, Wide L et al. Maternal and gestational correlates of pregnancy prolactin and growth hormone in USA and China. Eur J Cancer Prev 2003; 12: 35-42.
11. Troisi R, Lagiou P, Trichopoulos D et al. Cord serum estrogens, androgens, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 in Chinese and U.S. Caucasian neonates. Cancer Epidemiol Biomarkers Prev 2008; 17: 224-231.
12. Lagiou P, Hsieh CC, Lipworth L et al. Insulin-like growth factor levels in cord blood, birth weight and breast cancer risk. Br J Cancer 2009; 100: 1794-1798.
13. Hankinson S, Tamimi R, Hunter D. Breast cancer. In Adami HO, Hunter D, Trichopoulos D (eds), Textbook of Cancer Epidemiology, 2nd edition. New York: Oxford University Press 2008; 403-445.
14. Fortunati N, Catalano MG, Boccuzzi G, Frairia R. Sex Hormone-Binding Globulin (SHBG), estradiol and breast cancer. Mol Cell Endocrinol 2010; 316: 86-92.
15. Lipworth L, Adami HO, Trichopoulos D et al. Serum steroid hormone levels, sex hormone-binding globulin, and body mass index in the etiology of postmenopausal breast cancer. Epidemiology 1996; 7: 96-100.
16. Micheli A, Muti P, Secreto G et al. Endogenous sex hormones and subsequent breast cancer in premenopausal women. Int J Cancer 2004; 112: 312-318.
17. Eliassen AH, Missmer SA, Tworoger SS et al. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 2006; 98: 1406-1415.
18. Tworoger SS, Eliassen AH, Rosner B et al. Plasma prolactin concentrations and risk of postmenopausal breast cancer. Cancer Res 2004; 64: 6814-6819.
19. Miyoshi Y, Funahashi T, Kihara S et al. Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 2003; 9: 5699-5704.
20. Mantzoros C, Petridou E, Dessypris N et al. Adiponectin and breast cancer risk. J Clin Endocrinol Metab 2004; 89: 1102-1107.
21. The Endogenous Hormones and Breast Cancer Collaborative Group. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 2010; 11(6): 530-542.
22. Walker K, Fletcher O, Johnson N et al. Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factors. Cancer Res 2009; 69: 6490-6499.